Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Chongqing Zhifei Biological Products Co., Ltd.
  6. Financials
    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

(300122)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 62 01679 456236 656280 640--
Entreprise Value (EV)1 62 01680 690238 093276 346267 491256 847
P/E ratio 42,6x33,6x71,7x38,8x30,5x27,5x
Yield 1,29%1,01%0,34%0,62%0,83%0,83%
Capitalization / Revenue 11,9x7,50x15,6x10,8x8,66x8,31x
EV / Revenue 11,9x7,62x15,7x10,6x8,26x7,61x
EV / EBITDA 34,3x27,7x59,1x29,9x24,6x19,6x
Price to Book 14,9x13,8x28,7x18,7x12,1x8,34x
Nbr of stocks (in thousands) 1 600 0001 600 0001 600 0001 600 000--
Reference price (CNY) 38,849,7148175175175
Announcement Date 02/25/201902/27/202002/21/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 5 22810 58715 19026 00532 39533 759
EBITDA1 1 8062 9104 0279 22910 88213 123
Operating profit (EBIT)1 1 7132 8143 8957 6839 30710 054
Operating Margin 32,8%26,6%25,6%29,5%28,7%29,8%
Pre-Tax Profit (EBT)1 1 6922 7653 8548 45310 86112 427
Net income1 1 4512 3663 3017 3119 39810 623
Net margin 27,8%22,4%21,7%28,1%29,0%31,5%
EPS2 0,911,482,064,525,746,38
Dividend per Share2 0,500,500,501,091,461,45
Announcement Date 02/25/201902/27/202002/21/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q2 2019 Q3 2020 Q3 2021 Q2 2021 Q3 2021 Q4
Net sales1 2 7452 6274 0567 0185 9878 063
EBITDA ------
Operating profit (EBIT)1 ---2 2381 8712 620
Operating Margin ---31,9%31,2%32,5%
Pre-Tax Profit (EBT) ------
Net income --974---
Net margin --24,0%---
EPS2 ---1,180,981,39
Dividend per Share ------
Announcement Date 08/29/201910/21/201910/15/2020---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -1 2341 437---
Net Cash position1 ---4 29413 14923 793
Leverage (Debt / EBITDA) -0,42x0,36x-0,47x-1,21x-1,81x
Free Cash Flow1 1067942 67010 23317 06620 238
ROE (Net Profit / Equities) 40,8%47,7%46,3%54,7%37,8%30,5%
Shareholders' equity1 3 5594 9647 13213 36024 85934 813
ROA (Net Profit / Asset) 26,6%26,7%25,2%23,2%23,8%26,2%
Assets1 5 4588 87613 07931 46639 43340 547
Book Value Per Share2 2,613,595,169,3714,521,0
Cash Flow per Share2 0,370,852,192,294,576,74
Capex1 4795738271 0449981 003
Capex / Sales 9,16%5,41%5,44%4,02%3,08%2,97%
Announcement Date 02/25/201902/27/202002/21/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 280 640 000 000
Capitalization (USD) 43 401 741 390
Net sales (CNY) 15 190 366 230
Net sales (USD) 2 349 190 137
Number of employees 3 380
Sales / Employee (CNY) 4 494 191
Sales / Employee (USD) 695 027
Free-Float 14,7%
Free-Float capitalization (CNY) 41 327 748 000
Free-Float capitalization (USD) 6 391 448 941
Avg. Exchange 20 sessions (CNY) 3 222 519 486
Avg. Exchange 20 sessions (USD) 498 362 639
Average Daily Capital Traded 1,15%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA